Literature DB >> 9379297

Mast cell hyperplasia and increased macromolecular uptake in an animal model of giardiasis.

J A Hardin1, A G Buret, M E Olson, M H Kimm, D G Gall.   

Abstract

Giardiasis has been associated with an increase in allergic disease following infection suggesting an alteration in mucosal immune function. Jejunal in vivo and in vitro macromolecular transport, epithelial permeability, and mucosal and connective tissue mast cell counts were examined in Mongolian gerbils (35-45 g) orogastrically inoculated (I) with a pathogenic strain of Giardia lamblia and compared to age- and weight-matched, sham-treated controls (C) 6 and 21 days postinoculation. Macromolecular uptake was significantly increased in infected tissue at 6 days both in vivo (I 134 +/- 19 vs. C 74 +/- 17 ng/hr; n = 8; P < 0.05) and in vitro (I 125 +/- 17 vs. C 67 +/- 8 ng/hr/cm; n = 12; P < 0.05). Macromolecular uptake did not differ between groups at 21 days. Infection had no effect on mucosal permeability of [51Cr]EDTA. Mucosal mast cell counts did not differ at 6 days but were significantly elevated in infected tissue at 21 days (I 33.3 +/- 6.8 vs. C 2.7 +/- 0.4 per high magnification field; n = 5; P < 0.01) as were connective tissue mast cell counts (I 1.7 +/- 0.2 vs. C 1.0 +/- 0.1 per high magnification field; n = 13; P < 0.005). The findings indicate that during the peak phase of giardiasis, jejunal active antigen uptake is increased leading to a delayed recruitment of mucosal and connective tissue mast cells. These changes may play a role in the increased incidence of hypersensitivity reactions associated with Giardia infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9379297

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  25 in total

Review 1.  Intestinal mucosal responses to microbial infection.

Authors:  Lars Eckmann; Martin F Kagnoff
Journal:  Springer Semin Immunopathol       Date:  2005-06-01

Review 2.  Mechanisms of epithelial dysfunction in giardiasis.

Authors:  Andre G Buret
Journal:  Gut       Date:  2007-03       Impact factor: 23.059

3.  The course of experimental giardiasis in Mongolian gerbil.

Authors:  Radka Pecková; Bohumil Sak; Dana Květoňová; Martin Kváč; Eva Koriťáková; Ivona Foitová
Journal:  Parasitol Res       Date:  2018-05-24       Impact factor: 2.289

Review 4.  Giardia duodenalis: the double-edged sword of immune responses in giardiasis.

Authors:  Shahram Solaymani-Mohammadi; Steven M Singer
Journal:  Exp Parasitol       Date:  2010-06-18       Impact factor: 2.011

Review 5.  The Intersection of Immune Responses, Microbiota, and Pathogenesis in Giardiasis.

Authors:  Marc Y Fink; Steven M Singer
Journal:  Trends Parasitol       Date:  2017-08-19

6.  Mast cell-dependent control of Giardia lamblia infections in mice.

Authors:  Erqiu Li; Ping Zhou; Ziva Petrin; Steven M Singer
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

7.  Giardia duodenalis induces paracellular bacterial translocation and causes postinfectious visceral hypersensitivity.

Authors:  Marie C M Halliez; Jean-Paul Motta; Troy D Feener; Gaetan Guérin; Laetitia LeGoff; Arnaud François; Elodie Colasse; Loic Favennec; Gilles Gargala; Tamia K Lapointe; Christophe Altier; André G Buret
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-01-07       Impact factor: 4.052

8.  Giardia duodenalis cathepsin B proteases degrade intestinal epithelial interleukin-8 and attenuate interleukin-8-induced neutrophil chemotaxis.

Authors:  James A Cotton; Amol Bhargava; Jose G Ferraz; Robin M Yates; Paul L Beck; Andre G Buret
Journal:  Infect Immun       Date:  2014-04-14       Impact factor: 3.441

9.  Mast cell-mediated changes in smooth muscle contractility during mouse giardiasis.

Authors:  Erqiu Li; Aiping Zhao; Terez Shea-Donohue; Steven M Singer
Journal:  Infect Immun       Date:  2007-07-09       Impact factor: 3.441

10.  Giardia: both a harmless commensal and a devastating pathogen.

Authors:  Herbert L DuPont
Journal:  J Clin Invest       Date:  2013-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.